Treatment of specific disorders in poprhyria
Summary: Drugs used in the Management of HIV
This table should be read in conjunction with the page Management of HIV in patients with porphyria.
|
Use freely
|
Use with caution
|
Use with extreme
caution only |
Avoid
|
Unknown
|
ANTIRETROVIRAL AGENTS |
||||
| Nucleoside reverse transcriptase inhibitors (NRTI) | ||||
| Didanosine | Abacavir Lamivudine Stavudine Tenofovir Zalcitabine |
Zidovudine | Emtricitabine | |
| Non-nucleoside reverse transcriptase inhibitors (NNRTI) | ||||
| Nevirapine Efavirenz |
||||
| Protease inhibitors | ||||
| Saquinavir | Amprenavir Lopinavir Nelfinavir Ritonavir |
Indinavir | ||
ANTIMICROBIALS |
||||
| Pneumocystis | ||||
| Primaquine | Atovaquone Pentamidine |
Cotrimoxazole Dapsone Trimethoprim Clindamycin |
||
| Antifungals | ||||
| Amphotericin Nystatin |
Fluconazole Itraconazole |
Ketoconazole Miconazole |
||
| Herpes antivirals | ||||
| Aciclovir Famciclovir Valaciclovir Valganciclovir |
Foscarnet | |||
| Antimycobacterials | ||||
| Amikacin Streptomycin Ethambutol Kanamycin |
Ofloxacin | Isoniazid | Rifampicin Rifabutin Ethionamide Pyrazinamide |
Terizodone Clofazimine |
DISCLAIMER
Note that the safety of the drugs recommended here cannot be guaranteed. Many are newer drugs and there is still minimal actual clinical experienceof their use in porphyria. The responsibility for a decision to use any drug in porphyria is that of the doctor and his or her patient.